<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): October 6, 2000
OXBORO MEDICAL, INC.
---------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
MINNESOTA 0-18785 41-1391803
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
13828 Lincoln Street NE
Ham Lake, Minnesota 55304
-------------------- -------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (763) 755-9516
<PAGE>
Items 1, 2, 3, 4, 6, 7 and 8 are not applicable and therefore omitted.
ITEM 5. OTHER EVENTS.
Allan D. Anderson has been appointed to the Board of Directors of the
Registrant, effective October 6, 2000. Mr. Anderson is currently President of
RiverBend Solutions ("RiverBend"), having served in that capacity since August
2000. He is also the Chief Financial Officer of RiverBend, appointed in January
2000. He has also been a director of RiverBend since 1995. RiverBend provides
processing and customer services to not-for-profit credit counseling agencies
and their clients. Mr. Anderson was the President of Metropolitan Financial
Management, Inc. from 1997 to 1999 and served as its Treasurer from 1995 to
1999. He was a director of Metropolitan Financial Management, Inc. from 1991
through 1999. Prior to joining Metropolitan, he was the Chief Financial Officer
of Pan Am Systems, Inc. from 1994 through 1995.
J. David Berkley has accepted the position as President of the
Registrant, effective October 16, 2000. Incorporated herein is the attached
copy of the related press release issued October 17, 2000.
Linda Erickson has resigned as the Chief Financial Officer and
Secretary of the Registrant, effective October 31, 2000.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
OXBORO MEDICAL, INC.
By /s/ KENNETH W. BRIMMER
--------------------------------
Kenneth W. Brimmer
Chief Executive Officer
Dated: October 24, 2000
<PAGE>
------------------------------------------------------------------------------
OXBORO MEDICAL, INC.
13828 Lincoln Street NE For Further Information Contact:
Ham Lake, MN 55304-6949
KENNETH BRIMMER, CHAIRMAN
www.oxboromedical.com 612-669-8811
NASDAQ: OMED
------------------------------------------------------------------------------
DAVID BERKLEY JOINS OXBORO MEDICAL AS PRESIDENT
Oxboro Medical, Inc. (Nasdaq: OMED) announced today that J. David Berkley has
joined the company as President. Prior to joining Oxboro Medical, Mr. Berkley
was employed by Minnesota Mining and Manufacturing (3M) (NYSE: MMM) for more
than 22 years holding a variety of management positions including senior
leadership positions in the 3M Medical Surgical Products Division and the 3M
Health Care Sector.
Commenting on Mr. Berkley's appointment Oxboro Medical chairman, Kenneth Brimmer
noted, "Oxboro is fortunate to have an executive with Mr. Berkley's experience
as president and we expect Dave's strong surgical products background to be an
important asset to Oxboro." Mr. Brimmer added, "We expect that Dave's leadership
combined with important new e-commerce supply chain initiatives will begin a
period of growth at Oxboro."
Incorporated in Minnesota in 1978, Oxboro Medical, Inc. develops, assembles and
markets single-use and consumable products and supplies for medical and surgical
applications. Additional information is available at www.oxboromedical.com.
Forward-Looking Statements:
The Company may from time to time make written or oral "forward-looking
statements," whether in its news releases, its filings with the SEC or in its
reports to shareholders, or elsewhere. "Forward-looking statements" are
statements such as those contained in projections, plans, objectives, estimates,
statements of future economic performance, and assumptions related to any of the
foregoing, and may be identified by the use of forward-looking terminology, such
as "may," "expect," "anticipate," "estimate," "goal," "continue," or other
comparable terminology. By their very nature, forward-looking statements are
subject to known and unknown risks and uncertainties relating to the Company's
future performance that may cause the actual results, performance or
achievements of the Company, or industry results, to differ materially from
those expressed or implied in any such "forward-looking statements." Various
factors and risks (not all of which are identifiable at this time) could cause
the Company's results, performance or achievements to differ materially from
that contained in the Company's forward-looking statements, and investors are
cautioned that any forward-looking statement contained herein or elsewhere is
qualified by and subject to the warnings and cautionary statements contained
above and in its filings with the SEC. The Company does not undertake and
assumes no obligation to update any forward-looking statement that may be made
from time to time by or on behalf of the Company.
